The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Janus Kinase 3–Activating Mutations Identified in Natural Killer/T-cell Lymphoma
Abstract
The molecular pathogenesis of natural killer/T-cell lymphoma (NKTCL) is not well understood. We conducted whole-exome sequencing and identified Janus kinase 3 (JAK3) somatic–activating mutations (A572V and A573V) in 2 of 4 patients with NKTCLs. Further validation of the prevalence of JAK3 mutations was determined by Sanger sequencing and high-resolution melt (HRM) analysis in an additional 61 cases. In total, 23 of 65 (35.4%) cases harbored JAK3 mutations. Functional characterization of the JAK3 mutations support its involvement in cytokine-independent JAK/STAT constitutive activation leading to increased cell growth. Moreover, treatment of both JAK3-mutant and wild-type NKTCL cell lines with a novel pan-JAK inhibitor, CP-690550, resulted in dose-dependent reduction of phosphorylated STAT5, reduced cell viability, and increased apoptosis. Hence, targeting the deregulated JAK/STAT pathway could be a promising therapy for patients with NKTCLs. Significance: Gene mutations causing NKTCL have not been fully identified. Through exome sequencing, we identified activating mutations of JAK3 that may play a significant role in the pathogenesis of NKTCLs. Our findings have important implications for the management of patients with NKTCLs. Cancer Discov; 2(7); 591–7. ©2012 AACR. This article is highlighted in the In This Issue feature, p. 569.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
James, C., Ugo, V., Le Couédic, J.-P., Staerk, J., Delhommeau, F., Lacout, C., Garçon, L., Raslova, H., Berger, R., Bennaceur-Griscelli, A., et al. (2005) · Nature · doi:10.1038/nature03546 · Cited by 3,544
Somatic mutations affect key pathways in lung adenocarcinoma
Ding, L., Getz, G., Wheeler, D. A., Mardis, E. R., McLellan, M. D., Cibulskis, K., Sougnez, C., Greulich, H., Muzny, D. M., Morgan, M. B., et al. (2008) · Nature · doi:10.1038/nature07423 · Cited by 2,681 · cited 1×
“Besides hematologic neoplasia, nonhematologic cancers, including breast, stomach, and lung cancer, have also been found to harbor JAK3 mutations (17, 18).”
BackgroundInternational T-Cell Lymphoma Project (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.4558 · Cited by 2,108
Campo, E., Swerdlow, S. H., Harris, N. L., Pileri, S., Stein, H., & Jaffe, E. S. (2011) · Blood · doi:10.1182/blood-2011-01-293050 · Cited by 2,008
Prediction of deleterious human alleles
Sunyaev, S. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.6.591 · Cited by 1,044
Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome
Bercovich, D., Ganmore, I., Scott, L. M., Wainreb, G., Birger, Y., Elimelech, A., Shochat, C., Cazzaniga, G., Biondi, A., Basso, G., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61341-0 · Cited by 337
Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia
Flex, E., Petrangeli, V., Stella, L., Chiaretti, S., Hornakova, T., Knoops, L., Ariola, C., Fodale, V., Clappier, E., Paoloni, F., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072182 · Cited by 334
Activating alleles of JAK3 in acute megakaryoblastic leukemia
Walters, D. K., Mercher, T., Gu, T.-L., O'Hare, T., Tyner, J. W., Loriaux, M., Goss, V. L., Lee, K. A., Eide, C. A., Wong, M. J., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.06.002 · Cited by 317
Self-citationArray-based genomic resequencing of human leukemia
Yamashita, Y., Yuan, J., Suetake, I., Suzuki, H., Ishikawa, Y., Choi, Y. L., Ueno, T., Soda, M., Hamada, T., Haruta, H., et al. (2010) · Oncogene · doi:10.1038/onc.2010.117 · Cited by 249
Somatic Mutations of JAK1 and JAK3 in Acute Leukemias and Solid Cancers
Jeong, E. G., Kim, M. S., Nam, H. K., Min, C. K., Lee, S., Chung, Y. J., Yoo, N. J., & Lee, S. H. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4839 · Cited by 201
Suzuki, R., Handa, K., Itoh, K., & Kumagai, K. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.130.2.981 · Cited by 194
(2006) · New England Journal of Medicine · doi:10.1056/nejmc052564 · Cited by 189
Yagita, M., Huang, C., Umehara, H., Matsuo, Y., Tabata, R., Miyake, M., Konaka, Y., & Takatsuki, K. (2000) · Leukemia · doi:10.1038/sj.leu.2401769 · Cited by 186
Activating mutations in human acute megakaryoblastic leukemia
Malinge, S., Ragu, C., Della-Valle, V., Pisani, D. F., Constantinescu, S. N., Pérez, C., Villeval, J., Reinhardt, D., Landman‐Parker, J., Michaux, L., et al. (2008) · Blood · doi:10.1182/blood-2008-01-136366 · Cited by 145
Mutations in severe combined immune deficiency (SCID) due to JAK3 deficiency
Notarangelo, L. D., Mella, P., Jones, A., Basile, G. D. S., Savoldi, G., Cranston, T., Vihinen, M., & Schumacher, R. F. (2001) · Human Mutation · doi:10.1002/humu.1188 · Cited by 131
Kwong, Y., Anderson, B. O., Advani, R. H., Kim, W.-S., Levine, A. M., & Lim, S.-T. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70265-7 · Cited by 120
Self-citationJak3- and JNK-dependent vascular endothelial growth factor expression in cutaneous T-cell lymphoma
Krejsgaard, T., Vetter‐Kauczok, C. S., Woetmann, A., Lovato, P., Labuda, T., Eriksen, K., Zhang, Q., Becker, J. C., & Ødum, N. (2006) · Leukemia · doi:10.1038/sj.leu.2404350 · Cited by 116
FERM domain mutations induce gain of function in JAK3 in adult T-cell leukemia/lymphoma
Elliott, N., Cleveland, S. M., Grann, V. R., Janik, J. E., Waldmann, T. A., & Davé, U. P. (2011) · Blood · doi:10.1182/blood-2010-12-319467 · Cited by 91
Cornejo, M., Kharas, M. G., Werneck, M. B. F., Bras, S. L., Moore, S. A., Ball, B. J., Beylot-Barry, M., Rodig, S. J., Aster, J. C., Lee, B. H., et al. (2009) · Blood · doi:10.1182/blood-2008-06-164368 · Cited by 82
Kiyoi, H., Yamaji, S., Kojima, S., & Naoe, T. (2007) · Leukemia · doi:10.1038/sj.leu.2404527 · Cited by 82
Ju, W., Zhang, M., Jiang, J.-K., Thomas, C. J., Oh, U., Bryant, B. R., Chen, J., Sato, N., Tagaya, Y., Morris, J. C., et al. (2010) · Blood · doi:10.1182/blood-2010-09-305425 · Cited by 78
Solassol, J., Ramos, J., Lopez‐Crapez, E., Saifi, M., Mangé, A., Vianès, E., Lamy, P., Costes, V., & Maudelondé, T. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12053191 · Cited by 64
Manshouri, T., Quintás‐Cardama, A., Nussenzveig, R. H., Gaikwad, A. S., Estrov, Z. E., Prchal, J. T., Cortes, J. E., Kantarjian, H. M., & Verstovšek, S. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00817.x · Cited by 62
Jak‐STAT pathway is involved in the induction of TNF‐β gene during stimulation by IL‐2
Lu, L.-R., Zhu, J.-F., Zheng, Z., Yan, M., Xu, W.-J., Sun, L.-Y., Théze, J., & Liu, X.-Y. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199803)28:03<805::aid-immu805>3.0.co;2-g · Cited by 40
Activation Status of the JAK/STAT3 Pathway in Mantle Cell Lymphoma
Yared, M. A., Khoury, J. D., Medeiros, L. J., Rassidakis, G. Z., & Lai, R. L. (2005) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2005-129-990-asotsp · Cited by 33
An Epstein-Barr virus positive natural killer lymphoma xenograft derived for drug testing
Loong, S. L. E., Hwang, J. S. G., Lim, S.-T., et al. (2008) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190802043879 · Cited by 11
Self-citation
Cited by
The JAK/STAT signaling pathway: from bench to clinic
Hu, X., li, J., Fu, M., Zhao, X., & Wang, W. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00791-1 · Cited by 2,633
JAKs and STATs in immunity, immunodeficiency, and cancer
O'Shea, J. J., Holland, S. M., & Staudt, L. M. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1202117 · Cited by 927
Clark, J. D., Flanagan, M. E., & Telliez, J.-B. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401490p · Cited by 601
Epstein–Barr virus-associated lymphomas
Shannon-Lowe, C., Rickinson, A. B., & Bell, A. I. (2017) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2016.0271 · Cited by 428
Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells
Küçük, C., Jiang, B., Hu, X., Zhang, W., Chan, J. K. C., Xiao, W., Lack, N., Alkan, C., Williams, J. C., Avery, K. N., et al. (2015) · Nature Communications · doi:10.1038/ncomms7025 · Cited by 393
Metadata
- Authors
- Koo, G. C., Tan, S. Y., Tang, T., Poon, S. L., Allen, G. E., Tan, L., Chong, S. C., Ong, W. S., Tay, K., Tao, M., Quek, R., Loong, S., Yeoh, K.-W., Yap, S. P., Lee, K. A., Lim, L. C., Tan, D., Goh, C., Cutcutache, I., Yu, W., Young Ng, C. C., Rajasegaran, V., Heng, H. L., Gan, A., Ong, C. K., Rozen, S., Tan, P., Teh, B. T., & Lim, S. T.
- Venue
- Cancer Discovery
- Published
- 2012-07-01
- Volume
- 2
- Issue
- 7
- Pages
- 591-597
- ISSN
- 2159-8274 (ISSN-L)
- 2159-8290
- OpenAlex
- W2160289258
- Cited by
- 275
- References
- 26
- FWCI
- 11.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.